Logo image of BEX.CA

BENTON RESOURCES INC (BEX.CA) Stock Fundamental Analysis

TSX-V:BEX - TSX Venture Exchange - CA0832981090 - Common Stock - Currency: CAD

0.075  -0.01 (-6.25%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BEX. BEX was compared to 822 industry peers in the Metals & Mining industry. While BEX has a great health rating, there are worries on its profitability. BEX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BEX has reported negative net income.
BEX had a negative operating cash flow in the past year.
In the past 5 years BEX reported 4 times negative net income.
BEX had negative operating cash flow in 4 of the past 5 years.
BEX.CA Yearly Net Income VS EBIT VS OCF VS FCFBEX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

BEX has a Return On Assets (-39.50%) which is comparable to the rest of the industry.
BEX has a Return On Equity of -41.30%. This is comparable to the rest of the industry: BEX outperforms 47.39% of its industry peers.
Industry RankSector Rank
ROA -39.5%
ROE -41.3%
ROIC N/A
ROA(3y)-30.65%
ROA(5y)-14.37%
ROE(3y)-33.08%
ROE(5y)-15.65%
ROIC(3y)N/A
ROIC(5y)N/A
BEX.CA Yearly ROA, ROE, ROICBEX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BEX.CA Yearly Profit, Operating, Gross MarginsBEX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, BEX has more shares outstanding
BEX has more shares outstanding than it did 5 years ago.
BEX has a better debt/assets ratio than last year.
BEX.CA Yearly Shares OutstandingBEX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BEX.CA Yearly Total Debt VS Total AssetsBEX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

BEX has an Altman-Z score of 12.15. This indicates that BEX is financially healthy and has little risk of bankruptcy at the moment.
BEX's Altman-Z score of 12.15 is fine compared to the rest of the industry. BEX outperforms 78.79% of its industry peers.
There is no outstanding debt for BEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.15
ROIC/WACCN/A
WACCN/A
BEX.CA Yearly LT Debt VS Equity VS FCFBEX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

BEX has a Current Ratio of 5.73. This indicates that BEX is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.73, BEX is doing good in the industry, outperforming 79.76% of the companies in the same industry.
A Quick Ratio of 5.73 indicates that BEX has no problem at all paying its short term obligations.
BEX has a better Quick ratio (5.73) than 79.88% of its industry peers.
Industry RankSector Rank
Current Ratio 5.73
Quick Ratio 5.73
BEX.CA Yearly Current Assets VS Current LiabilitesBEX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for BEX have decreased strongly by -972.41% in the last year.
EPS 1Y (TTM)-972.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BEX.CA Yearly Revenue VS EstimatesBEX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
BEX.CA Yearly EPS VS EstimatesBEX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BEX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BEX.CA Price Earnings VS Forward Price EarningsBEX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BEX.CA Per share dataBEX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BENTON RESOURCES INC

TSX-V:BEX (3/7/2025, 7:00:00 PM)

0.075

-0.01 (-6.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners19.16%
Ins Owner ChangeN/A
Market Cap15.42M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.5%
ROE -41.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.65%
ROA(5y)-14.37%
ROE(3y)-33.08%
ROE(5y)-15.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7233.58%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.73
Quick Ratio 5.73
Altman-Z 12.15
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5300.67%
Cap/Depr(5y)4771.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-972.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.22%
OCF growth 3YN/A
OCF growth 5Y-34.15%